Cite

HARVARD Citation

    Agarwal, S. et al. (2022). The Changing Use and Benefits of Anti–SARS-CoV-2 Monoclonal Antibodies. Infectious diseases in clinical practice. 30 (2), p. . [Online]. 
  
Back to record